跳至主要内容
临床试验/CTRI/2016/05/006908
CTRI/2016/05/006908进行中(未招募)未知

Management of convulsive status epilepticus in children with Phenytoin Vs Valproate Vs Levetiracetam: A randomized double blinded control trial.

The Director0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children aged 3 months to 12 years of adult parents who present with CSE (clonic, tonic, tonic clonic, and myoclonic, focal or generalized) to Pediatric Critical Care Units.

排除标准

  • 1.Non¬-convulsive status epilepticus (NCSE).
  • 2.Active or recent hemorrhage ( <1 week) from any site.
  • 3.Documented platelet count <50,000, or INR >2
  • 4.Head injury or neurosurgery in the past one month.
  • 5.Acute or chronic liver or kidney disease.
  • 6.Suspected or known structural malformation or neurometabolic or mitochondrial disorders
  • 7.Known or suspected allergy or intolerance to phenytoin or valproate or levetiracetam
  • 8.Patients of epilepsy already on Levetiracetam ( > 20 mg/kg/day) or Valproate ( > 20mg/kg/day) or Phenytoin ( > 5 mg/kg/day) for more than 1 month.
  • 9.Patients received appropriate dose of documented Levetiracetam or Valproate or Phenytoin outside hospital setting for this episode of CSE.

研究者

发起方
The Director

相似试验